- 2024-08-20 02:05抑制剂NBD-556|NBD-556|333353-44-9|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:05抑制剂Nampt-IN-1|Nampt-IN-1|1698878-14-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:05抑制剂Nampt-IN-1|Nampt-IN-1|1698878-14-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:05抑制剂N-Arachidonyl-GABA|N-Arachidonyl-GABA|128201-89-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:05抑制剂N1-Methylpseudouridine|N1-Methylpseudouridine|13860-38-3|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:05抑制剂N1-Methylpseudouridine|N1-Methylpseudouridine|13860-38-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:05抑制剂N1-Methylpseudouridine|N1-Methylpseudouridine|13860-38-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:05抑制剂Nampt-IN-1|Nampt-IN-1|1698878-14-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:05抑制剂N106|N106|862974-25-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:05抑制剂N106|N106|862974-25-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:05抑制剂N106|N106|862974-25-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:05抑制剂N-(p-Coumaroyl) Serotonin|N-(p-Coumaroyl) Serotonin|68573-24-0|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:05抑制剂N-(p-Coumaroyl) Serotonin|N-(p-Coumaroyl) Serotonin|68573-24-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:05抑制剂N-(p-Coumaroyl) Serotonin|N-(p-Coumaroyl) Serotonin|68573-24-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:05抑制剂MYLS22|MYLS22|306959-01-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:05抑制剂MYLS22|MYLS22|306959-01-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:05抑制剂MYLS22|MYLS22|306959-01-3|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:04抑制剂MV1|MV1|1001600-54-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:04抑制剂MTX-211|MTX-211|1952236-05-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:04抑制剂MV1|MV1|1001600-54-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
